• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳寡糖类似物二岩藻基-β-环糊精的消化、发酵和抗病原体黏附特性。

Digestion, fermentation, and pathogen anti-adhesive properties of the hMO-mimic di-fucosyl-β-cyclodextrin.

机构信息

Stratingh Institute for Chemistry, University of Groningen, Groningen, the Netherlands.

Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands.

出版信息

Food Funct. 2021 Jun 8;12(11):5018-5026. doi: 10.1039/d1fo00830g.

DOI:10.1039/d1fo00830g
PMID:33954318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8185958/
Abstract

Human milk is widely acknowledged as the best food for infants, and that is not just because of nutritional features. Human milk also contains a plethora of bioactive molecules, including a large set of human milk oligosaccharides (hMOs). Especially fucosylated hMOs have received attention for their anti-adhesive effects on pathogens, preventing attachment to the intestine and infection. Because hMOs are generally challenging to produce in sufficient quantities to study and ultimately apply in (medical) infant formula, novel compounds that are inspired by hMO structures (so-called "mimics") are interesting compounds to produce and evaluate for their biological effects. Here we present our thorough study into the digestion, fermentation and anti-adhesive capacity of the novel compound di-fucosyl-β-cyclodextrin (DFβCD), which was inspired by the molecular structures of hMOs. We establish that DFβCD is not digested by α-amylase and also resistant to fermentation by microbial enzymes from a 9 month-old infant inoculum. In addition, we reveal that DFβCD blocks adhesion of enterotoxigenic E. coli (ETEC) to Caco-2 cells, especially when DFβCD is pre-incubated with ETEC prior to addition to the Caco-2 cells. This suggests that DFβCD functions through a decoy effect. We expect that our results inspire the generation and biological evaluation of other fucosylated hMOs and mimics, to obtain a comprehensive overview of the anti-adhesive power of fucosylated glycans.

摘要

人乳被广泛认为是婴儿的最佳食物,这不仅仅是因为其营养成分。人乳还含有大量生物活性分子,包括一大组人乳低聚糖(hMOs)。特别是岩藻糖基 hMOs 因其对病原体的抗粘附作用而受到关注,可防止其附着在肠道上并感染。由于 hMOs 通常难以大量生产以进行研究并最终应用于(医学)婴儿配方奶粉中,因此受 hMO 结构启发的新型化合物(所谓的“模拟物”)是很有前途的生产和评估其生物效应的化合物。在这里,我们对受 hMO 分子结构启发的新型化合物二岩藻糖基-β-环糊精(DFβCD)的消化、发酵和抗粘附能力进行了深入研究。我们确定 α-淀粉酶不能消化 DFβCD,并且它也能抵抗来自 9 个月大婴儿接种物的微生物酶的发酵。此外,我们揭示了 DFβCD 可以阻止肠产毒性大肠杆菌(ETEC)与 Caco-2 细胞的粘附,尤其是当 DFβCD 在添加到 Caco-2 细胞之前与 ETEC 预孵育时。这表明 DFβCD 通过诱饵效应发挥作用。我们期望我们的结果能够激发其他岩藻糖基 hMOs 和模拟物的生成和生物学评估,以全面了解岩藻糖基聚糖的抗粘附能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/161ee1020d0d/d1fo00830g-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/d1aadf9706f4/d1fo00830g-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/d1126be09676/d1fo00830g-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/cb2dfa644bb4/d1fo00830g-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/161ee1020d0d/d1fo00830g-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/d1aadf9706f4/d1fo00830g-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/d1126be09676/d1fo00830g-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/cb2dfa644bb4/d1fo00830g-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344c/8185958/161ee1020d0d/d1fo00830g-f4.jpg

相似文献

1
Digestion, fermentation, and pathogen anti-adhesive properties of the hMO-mimic di-fucosyl-β-cyclodextrin.人乳寡糖类似物二岩藻基-β-环糊精的消化、发酵和抗病原体黏附特性。
Food Funct. 2021 Jun 8;12(11):5018-5026. doi: 10.1039/d1fo00830g.
2
Enzymatic and cell factory approaches to the production of human milk oligosaccharides.酶法和细胞工厂方法生产人乳寡糖。
Biotechnol Adv. 2019 Sep-Oct;37(5):667-697. doi: 10.1016/j.biotechadv.2019.03.014. Epub 2019 Mar 29.
3
Beneficial effects of human milk oligosaccharides on gut microbiota.人乳寡糖对肠道微生物群的有益作用。
Benef Microbes. 2014 Sep;5(3):273-83. doi: 10.3920/BM2013.0080.
4
Fucosylated Human Milk Oligosaccharide Foraging within the Species Bifidobacterium pseudocatenulatum Is Driven by Glycosyl Hydrolase Content and Specificity.岩藻糖基化人乳寡糖在双歧杆菌假长双歧亚种内的觅食受糖基水解酶含量和特异性的驱动。
Appl Environ Microbiol. 2022 Jan 25;88(2):e0170721. doi: 10.1128/AEM.01707-21. Epub 2021 Nov 10.
5
Infant Gut Microbial Metagenome Mining of α-l-Fucosidases with Activity on Fucosylated Human Milk Oligosaccharides and Glycoconjugates.婴儿肠道微生物宏基因组挖掘具有α-L-岩藻糖苷酶活性的 α-L-岩藻糖苷酶,可作用于人乳寡糖和糖缀合物。
Microbiol Spectr. 2022 Aug 31;10(4):e0177522. doi: 10.1128/spectrum.01775-22. Epub 2022 Aug 9.
6
Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.将人乳寡糖、婴儿粪便群落类型与日后使用抗生素的风险联系起来。
mBio. 2020 Mar 17;11(2):e03196-19. doi: 10.1128/mBio.03196-19.
7
Human milk oligosaccharides: every baby needs a sugar mama.人乳寡糖:每个宝宝都需要一个糖妈妈。
Glycobiology. 2012 Sep;22(9):1147-62. doi: 10.1093/glycob/cws074. Epub 2012 Apr 18.
8
The functional biology of human milk oligosaccharides.人乳寡糖的功能生物学
Early Hum Dev. 2015 Nov;91(11):619-22. doi: 10.1016/j.earlhumdev.2015.09.001. Epub 2015 Sep 12.
9
Human milk oligosaccharides: prebiotics and beyond.人乳寡糖:益生元及其他。
Nutr Rev. 2009 Nov;67 Suppl 2:S183-91. doi: 10.1111/j.1753-4887.2009.00239.x.
10
α-L-Fucosidases and their applications for the production of fucosylated human milk oligosaccharides.α-L-岩藻糖苷酶及其在人乳寡糖岩藻糖基化生产中的应用。
Appl Microbiol Biotechnol. 2020 Jul;104(13):5619-5631. doi: 10.1007/s00253-020-10635-7. Epub 2020 May 1.

引用本文的文献

1
Modifiable and Non-Modifiable Factors That Affect Human Milk Oligosaccharides Composition.影响人乳寡糖组成的可调节和不可调节因素。
Nutrients. 2024 Aug 28;16(17):2887. doi: 10.3390/nu16172887.
2
Unraveling the gut microbiome's contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives.揭开肠道微生物组对胰腺导管腺癌的贡献:机制见解和治疗观点。
Front Immunol. 2024 Jul 9;15:1434771. doi: 10.3389/fimmu.2024.1434771. eCollection 2024.
3
Characterization and stabilization of the α-L-fucosidase set from Lacticaseibacillus rhamnosus INIA P603.

本文引用的文献

1
Impact of dietary fibers in infant formulas on gut microbiota and the intestinal immune barrier.婴儿配方食品中膳食纤维对肠道菌群和肠道免疫屏障的影响。
Food Funct. 2020 Nov 18;11(11):9445-9467. doi: 10.1039/d0fo01700k.
2
Human milk oligosaccharides as bioactive compounds in infant formula: recent advances and trends in synthetic methods.人乳寡糖作为婴儿配方奶粉中的生物活性化合物:合成方法的最新进展和趋势。
Crit Rev Food Sci Nutr. 2022;62(1):181-214. doi: 10.1080/10408398.2020.1813683. Epub 2020 Sep 11.
3
Human milk oligosaccharides: Shaping the infant gut microbiota and supporting health.
鼠李糖乳杆菌INIA P603中α-L-岩藻糖苷酶的特性鉴定与稳定性研究
Appl Microbiol Biotechnol. 2022 Dec;106(24):8067-8077. doi: 10.1007/s00253-022-12262-w. Epub 2022 Nov 12.
人乳寡糖:塑造婴儿肠道微生物群并促进健康。
J Funct Foods. 2020 Sep;72:104074. doi: 10.1016/j.jff.2020.104074. Epub 2020 Jul 3.
4
Infant Formula Supplemented with Biotics: Current Knowledge and Future Perspectives.添加益生菌的婴儿配方奶粉:当前知识和未来展望。
Nutrients. 2020 Jun 30;12(7):1952. doi: 10.3390/nu12071952.
5
Anti-Pathogenic Functions of Non-Digestible Oligosaccharides In Vitro.体外不可消化低聚糖的抗病原体功能。
Nutrients. 2020 Jun 16;12(6):1789. doi: 10.3390/nu12061789.
6
The Protective Effects of 2'-Fucosyllactose against O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion.2'-岩藻糖基乳糖通过调节肠道菌群和抑制病原菌黏附发挥抗 O157 感染的保护作用。
Nutrients. 2020 May 1;12(5):1284. doi: 10.3390/nu12051284.
7
More than sugar in the milk: human milk oligosaccharides as essential bioactive molecules in breast milk and current insight in beneficial effects.不仅是牛奶中的糖:人乳寡糖作为母乳中的必需生物活性分子及有益作用的最新认识
Crit Rev Food Sci Nutr. 2021;61(7):1184-1200. doi: 10.1080/10408398.2020.1754756. Epub 2020 Apr 24.
8
The Impact of Dietary Fucosylated Oligosaccharides and Glycoproteins of Human Milk on Infant Well-Being.母乳中含岩藻糖基化低聚糖和糖蛋白的膳食对婴儿健康的影响。
Nutrients. 2020 Apr 16;12(4):1105. doi: 10.3390/nu12041105.
9
Breast Milk, a Source of Beneficial Microbes and Associated Benefits for Infant Health.母乳:有益微生物的来源及其对婴儿健康的益处。
Nutrients. 2020 Apr 9;12(4):1039. doi: 10.3390/nu12041039.
10
Synthesis of Human Milk Oligosaccharides: Protein Engineering Strategies for Improved Enzymatic Transglycosylation.人乳寡糖的合成:提高酶转糖苷作用的蛋白质工程策略。
Molecules. 2019 May 28;24(11):2033. doi: 10.3390/molecules24112033.